Lexicon Pharmaceuticals, Inc. (LXRX)
USD 0.4
(-5.2%)
USD 0.4
(-5.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -163.46 Million USD | -72.64% |
| 2022 | -98.73 Million USD | -14.04% |
| 2021 | -86.66 Million USD | 50.6% |
| 2020 | -41.09 Million USD | -201.49% |
| 2019 | 173.73 Million USD | 273.83% |
| 2018 | -96.08 Million USD | 24.77% |
| 2017 | -125.27 Million USD | 2.17% |
| 2016 | -125.81 Million USD | -1272.3% |
| 2015 | 11.71 Million USD | 113.84% |
| 2014 | -96.18 Million USD | 19.91% |
| 2013 | -99.29 Million USD | -6.27% |
| 2012 | -103.9 Million USD | 13.73% |
| 2011 | -108.8 Million USD | -19.58% |
| 2010 | -93.68 Million USD | -6.87% |
| 2009 | -84.29 Million USD | -7.26% |
| 2008 | -86.26 Million USD | -30.29% |
| 2007 | -64.53 Million USD | -43.45% |
| 2006 | -39.97 Million USD | -77.43% |
| 2005 | -24.48 Million USD | 30.22% |
| 2004 | -34.58 Million USD | 12.61% |
| 2003 | -41.06 Million USD | 2.96% |
| 2002 | -42.31 Million USD | -56.2% |
| 2001 | -27.08 Million USD | 17.55% |
| 2000 | -32.85 Million USD | -204.22% |
| 1999 | -10.8 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -45.18 Million USD | -0.6% |
| 2024 Q2 | -55.21 Million USD | -14.91% |
| 2023 FY | - USD | -72.64% |
| 2023 Q3 | -46.62 Million USD | -8.57% |
| 2023 Q2 | -42.94 Million USD | -42.61% |
| 2023 Q1 | -30.11 Million USD | -2.46% |
| 2023 Q4 | -46.59 Million USD | 0.08% |
| 2022 Q3 | -22.41 Million USD | 6.15% |
| 2022 FY | - USD | -14.04% |
| 2022 Q1 | -23.25 Million USD | 8.13% |
| 2022 Q2 | -23.88 Million USD | -2.7% |
| 2022 Q4 | -29.39 Million USD | -31.12% |
| 2021 Q2 | -17.89 Million USD | 13.76% |
| 2021 FY | - USD | 50.6% |
| 2021 Q1 | -20.75 Million USD | -226.83% |
| 2021 Q3 | -22.95 Million USD | -28.23% |
| 2021 Q4 | -25.31 Million USD | -10.3% |
| 2020 FY | - USD | -201.49% |
| 2020 Q4 | -6.35 Million USD | 85.91% |
| 2020 Q1 | -60.57 Million USD | -31.83% |
| 2020 Q2 | -61.44 Million USD | -1.44% |
| 2020 Q3 | -45.05 Million USD | 26.67% |
| 2019 Q3 | 254.82 Million USD | 1527.25% |
| 2019 Q1 | -15.77 Million USD | -36.53% |
| 2019 Q2 | -17.85 Million USD | -13.15% |
| 2019 Q4 | -45.94 Million USD | -118.03% |
| 2019 FY | - USD | 273.83% |
| 2018 Q3 | -21.34 Million USD | 25.35% |
| 2018 Q1 | -36.03 Million USD | -19.23% |
| 2018 FY | - USD | 24.77% |
| 2018 Q2 | -28.59 Million USD | 20.66% |
| 2018 Q4 | -11.55 Million USD | 45.85% |
| 2017 FY | - USD | 2.17% |
| 2017 Q4 | -30.22 Million USD | -7.25% |
| 2017 Q3 | -28.18 Million USD | 13.36% |
| 2017 Q2 | -32.52 Million USD | 18.38% |
| 2017 Q1 | -39.85 Million USD | -29.46% |
| 2016 Q4 | -30.78 Million USD | 15.69% |
| 2016 Q3 | -36.51 Million USD | -2.92% |
| 2016 Q1 | -32.26 Million USD | -135.67% |
| 2016 FY | - USD | -1272.3% |
| 2016 Q2 | -35.48 Million USD | -9.95% |
| 2015 Q1 | -24.62 Million USD | -1950.04% |
| 2015 Q4 | 90.45 Million USD | 424.9% |
| 2015 Q3 | -27.84 Million USD | -6.33% |
| 2015 Q2 | -26.18 Million USD | -6.35% |
| 2015 FY | - USD | 113.84% |
| 2014 FY | - USD | 19.91% |
| 2014 Q4 | -1.2 Million USD | 95.71% |
| 2014 Q3 | -28.01 Million USD | -11.52% |
| 2014 Q2 | -25.12 Million USD | 12.13% |
| 2014 Q1 | -28.59 Million USD | -28.64% |
| 2013 FY | - USD | -6.27% |
| 2013 Q2 | -28.1 Million USD | -20.06% |
| 2013 Q1 | -23.41 Million USD | 4.65% |
| 2013 Q3 | -29.25 Million USD | -4.07% |
| 2013 Q4 | -22.22 Million USD | 24.02% |
| 2012 Q4 | -24.55 Million USD | 15.52% |
| 2012 FY | - USD | 13.73% |
| 2012 Q2 | -25.5 Million USD | 9.74% |
| 2012 Q3 | -29.06 Million USD | -13.97% |
| 2012 Q1 | -28.25 Million USD | 12.16% |
| 2011 Q4 | -32.16 Million USD | -31.56% |
| 2011 Q1 | -27.85 Million USD | -32.26% |
| 2011 Q2 | -24.69 Million USD | 11.36% |
| 2011 Q3 | -24.45 Million USD | 0.98% |
| 2011 FY | - USD | -19.58% |
| 2010 Q3 | -22.86 Million USD | -3.37% |
| 2010 FY | - USD | -6.87% |
| 2010 Q2 | -22.11 Million USD | 3.8% |
| 2010 Q1 | -22.99 Million USD | -13.61% |
| 2010 Q4 | -21.06 Million USD | 7.89% |
| 2009 Q3 | -21.65 Million USD | 3.81% |
| 2009 FY | - USD | -7.26% |
| 2009 Q2 | -22.51 Million USD | -5.34% |
| 2009 Q1 | -21.37 Million USD | -16.15% |
| 2009 Q4 | -20.23 Million USD | 6.54% |
| 2008 Q1 | -21.29 Million USD | -47.67% |
| 2008 Q3 | -20.1 Million USD | 13.48% |
| 2008 Q2 | -23.24 Million USD | -9.12% |
| 2008 FY | - USD | -30.29% |
| 2008 Q4 | -18.39 Million USD | 8.49% |
| 2007 FY | - USD | -43.45% |
| 2007 Q2 | -15.48 Million USD | 6.78% |
| 2007 Q3 | -17.21 Million USD | -11.12% |
| 2007 Q4 | -14.42 Million USD | 16.2% |
| 2007 Q1 | -16.61 Million USD | -33.27% |
| 2006 Q4 | -12.46 Million USD | -24.48% |
| 2006 Q1 | -8.03 Million USD | -195.64% |
| 2006 FY | - USD | -77.43% |
| 2006 Q2 | -13.91 Million USD | -73.3% |
| 2006 Q3 | -10.01 Million USD | 28.04% |
| 2005 FY | - USD | 30.22% |
| 2005 Q1 | -10.7 Million USD | -725.83% |
| 2005 Q2 | -11.6 Million USD | -8.37% |
| 2005 Q3 | -11.12 Million USD | 4.11% |
| 2005 Q4 | 8.39 Million USD | 175.47% |
| 2004 Q1 | -11.65 Million USD | -66.79% |
| 2004 FY | - USD | 12.61% |
| 2004 Q3 | -11.1 Million USD | 17.97% |
| 2004 Q4 | 1.71 Million USD | 115.41% |
| 2004 Q2 | -13.53 Million USD | -16.18% |
| 2003 FY | - USD | 2.96% |
| 2003 Q3 | -9.45 Million USD | 24.26% |
| 2003 Q4 | -6.98 Million USD | 26.07% |
| 2003 Q1 | -12.15 Million USD | -32.57% |
| 2003 Q2 | -12.47 Million USD | -2.69% |
| 2002 FY | - USD | -56.2% |
| 2002 Q4 | -9.16 Million USD | 25.06% |
| 2002 Q3 | -12.23 Million USD | -15.91% |
| 2002 Q2 | -10.55 Million USD | -1.77% |
| 2002 Q1 | -10.36 Million USD | -32.03% |
| 2001 Q1 | -7.13 Million USD | 74.77% |
| 2001 FY | - USD | 17.55% |
| 2001 Q4 | -7.85 Million USD | -114.82% |
| 2001 Q3 | -3.65 Million USD | 56.75% |
| 2001 Q2 | -8.45 Million USD | -18.52% |
| 2000 Q4 | -28.26 Million USD | -2381.31% |
| 2000 Q1 | -975.06 Thousand USD | 0.0% |
| 2000 FY | - USD | -204.22% |
| 2000 Q3 | -1.13 Million USD | 53.99% |
| 2000 Q2 | -2.47 Million USD | -153.92% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | 14.933% |
| Alkermes plc | 495.04 Million USD | 133.02% |
| Agenus Inc. | -145.92 Million USD | -12.02% |
| Aptorum Group Limited | -9.59 Million USD | -1602.928% |
| Ardelyx, Inc. | -55.35 Million USD | -195.307% |
| Dyadic International, Inc. | -8.22 Million USD | -1886.26% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -56073.196% |
| Lantern Pharma Inc. | -15.78 Million USD | -935.455% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -720.916% |
| Novavax, Inc. | -487.39 Million USD | 66.461% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -130.153% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -108.253% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -809.475% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -1539.888% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -184.9% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 56.98% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -577.939% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 31000.567% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -3.988% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -118.491% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -710.874% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -588.704% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -608.925% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -33.874% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 36.701% |
| AlloVir, Inc. | -190.14 Million USD | 14.032% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 6.949% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -458.698% |
| Bicycle Therapeutics plc | -183.4 Million USD | 10.87% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 1.183% |
| ChromaDex Corporation | -3.89 Million USD | -4097.843% |
| Chimerix, Inc. | -92.97 Million USD | -75.817% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -267.858% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -45.257% |
| CRISPR Therapeutics AG | -202.7 Million USD | 19.357% |
| Precision BioSciences, Inc. | -32.04 Million USD | -410.155% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 5.089% |
| Fortress Biotech, Inc. | -133.64 Million USD | -22.314% |
| Fortress Biotech, Inc. | -133.64 Million USD | -22.314% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -111.349% |
| ImmuCell Corporation | -2.5 Million USD | -6427.914% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -25.336% |
| Immix Biopharma, Inc. | -16.13 Million USD | -913.061% |
| Incyte Corporation | 919.42 Million USD | 117.779% |
| Innoviva, Inc. | 248.96 Million USD | 165.659% |
| IO Biotech, Inc. | -91.22 Million USD | -79.182% |
| Jaguar Health, Inc. | -33.13 Million USD | -393.387% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -7.417% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 260.689% |
| ContextLogic Inc. | -324 Million USD | 49.548% |
| MiMedx Group, Inc. | 40.51 Million USD | 503.445% |
| MEI Pharma, Inc. | 26.38 Million USD | 719.651% |
| NextCure, Inc. | -59.03 Million USD | -176.875% |
| Onconetix, Inc. | -36.7 Million USD | -345.324% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 7413.826% |
| Opthea Limited | -200.01 Million USD | 18.276% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -5840.732% |
| Vaxcyte, Inc. | -464.88 Million USD | 64.838% |
| PDS Biotechnology Corporation | -40.08 Million USD | -307.794% |
| Precigen, Inc. | -89.22 Million USD | -83.202% |
| Pharming Group N.V. | 9.87 Million USD | 1754.996% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -2.776% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -618.144% |
| PureTech Health plc | -11.62 Million USD | -1305.9% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -862.629% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 29.993% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -577.939% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -86.972% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -464.389% |
| Acelyrin, Inc. | -381.52 Million USD | 57.155% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1268548.782% |
| Summit Therapeutics Inc. | 1 Million USD | 16430.07% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -389.618% |
| Senti Biosciences, Inc. | -61.33 Million USD | -166.506% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -45.555% |
| Elevation Oncology, Inc. | -41.46 Million USD | -294.203% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -428.941% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -2572.489% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -50823.364% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -403.695% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -1846.927% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -178.047% |
| Seer, Inc. | -97.88 Million USD | -66.996% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -162.817% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -150.079% |
| ESSA Pharma Inc. | -26.45 Million USD | -517.887% |
| GlycoMimetics, Inc. | -39.12 Million USD | -317.831% |
| GT Biopharma, Inc. | 5.97 Million USD | 2833.969% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 20.915% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -2280.082% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 288.297% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -188.022% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -219.147% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -1553.338% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 69.725% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -2274.55% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -248.82% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 30.918% |
| Aptose Biosciences Inc. | -52.26 Million USD | -212.742% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -51.716% |
| Soligenix, Inc. | -7.85 Million USD | -1981.588% |
| Century Therapeutics, Inc. | -121.2 Million USD | -34.862% |
| Kura Oncology, Inc. | -164.95 Million USD | 0.904% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -104.08% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -1520.702% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -16967.698% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -3693.548% |
| Autolus Therapeutics plc | -156.77 Million USD | -4.27% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -93.09% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -136.901% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -720.026% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 13.636% |
| GRI Bio, Inc. | -10.89 Million USD | -1399.945% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -3519.892% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -33.433% |
| IGM Biosciences, Inc. | -253.35 Million USD | 35.481% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -57.492% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -328.666% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -966.238% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -938.312% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -187.561% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -52.623% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 38.547% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 15.714% |
| Verastem, Inc. | -83.16 Million USD | -96.551% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -223.23% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -3.309% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -43.278% |
| Histogen Inc. | -10.5 Million USD | -1456.355% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -1044.729% |
| Surrozen, Inc. | -41.13 Million USD | -297.423% |
| Organovo Holdings, Inc. | -14.8 Million USD | -1004.039% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 5097200.094% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -178.411% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -218.681% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -658.921% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -1860.469% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 1.567% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -231.85% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -576.421% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -985.776% |
| Apollomics, Inc. | -171.74 Million USD | 4.823% |
| Amarin Corporation plc | -50.9 Million USD | -221.138% |
| Mesoblast Limited | -61.33 Million USD | -166.528% |
| Turnstone Biologics Corp. | -56.23 Million USD | -190.685% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -14.15% |
| Synaptogenix, Inc. | -8.3 Million USD | -1867.666% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -965.676% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -159.273% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3311.565% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 38200.033% |
| Exelixis, Inc. | 196.6 Million USD | 183.145% |
| Better Therapeutics, Inc. | -38.26 Million USD | -327.223% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -15.597% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 66.991% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1285.798% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 66221.934% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -454.003% |
| Gritstone bio, Inc. | -126.86 Million USD | -28.851% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -151.541% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -3986.655% |
| Avid Bioservices, Inc. | -11.48 Million USD | -1323.778% |
| Insmed Incorporated | -654.73 Million USD | 75.034% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -7165.974% |
| MediWound Ltd. | -4.89 Million USD | -3240.773% |
| OmniAb, Inc. | -49.73 Million USD | -228.696% |
| Alector, Inc. | -142.89 Million USD | -14.397% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -91.334% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -213.462% |
| Zai Lab Limited | -366.57 Million USD | 55.408% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 43.757% |
| Aura Biosciences, Inc. | -83.69 Million USD | -95.307% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 27.43% |
| Immunic, Inc. | -99.11 Million USD | -64.929% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -24.147% |
| Veracyte, Inc. | -49.4 Million USD | -230.839% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -2214.066% |
| FibroGen, Inc. | -261.4 Million USD | 37.467% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1367.229% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2234.757% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -773.351% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 111.278% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -543.002% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 509.787% |
| TG Therapeutics, Inc. | 26.1 Million USD | 726.299% |
| Galecto, Inc. | -37.51 Million USD | -335.683% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -327.189% |
| Fortrea Holdings Inc. | 167.3 Million USD | 197.707% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -21.734% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -477.387% |
| XBiotech Inc. | -35.76 Million USD | -357.037% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -151.541% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -150.52% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -56.492% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -536.74% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -299.99% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 68.349% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -191.791% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -291534.404% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -40.511% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -637.336% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 30.46% |
| NexImmune, Inc. | -28.16 Million USD | -480.328% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -2858.331% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1286.196% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 103.512% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -543.762% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1295.56% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -29.892% |
| Ainos, Inc. | -8.77 Million USD | -1763.241% |
| Pluri Inc. | -20.22 Million USD | -708.227% |
| Prothena Corporation plc | -190.1 Million USD | 14.015% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -27.509% |
| Celularity Inc. | -183.94 Million USD | 11.135% |
| Rallybio Corporation | -72.37 Million USD | -125.863% |
| Cue Biopharma, Inc. | -46.05 Million USD | -254.955% |
| MeiraGTx Holdings plc | -57.05 Million USD | -186.518% |
| Omeros Corporation | -163.61 Million USD | 0.089% |
| Humacyte, Inc. | -96.45 Million USD | -69.467% |
| Immunocore Holdings plc | -59.64 Million USD | -174.043% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -743.816% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -570.897% |
| Blueprint Medicines Corporation | -474.61 Million USD | 65.558% |
| CalciMedica, Inc. | -34.18 Million USD | -378.119% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -123.208% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -30.253% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 2.961% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 35.234% |
| Pulmatrix, Inc. | -12.64 Million USD | -1192.614% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -395.856% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -84.774% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 67.715% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -61.502% |
| Cytokinetics, Incorporated | -456.68 Million USD | 64.206% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -389.809% |
| Nutriband Inc. | -5.12 Million USD | -3091.549% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -277.759% |
| Vor Biopharma Inc. | -114.37 Million USD | -42.924% |
| Roivant Sciences Ltd. | -996.51 Million USD | 83.596% |
| Evogene Ltd. | -23.2 Million USD | -604.465% |
| ProKidney Corp. | -147.66 Million USD | -10.696% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -153.295% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -106635.271% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 71.092% |
| CorMedix Inc. | -48.88 Million USD | -234.371% |
| BioLineRx Ltd. | -57.06 Million USD | -186.472% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -46.266% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -80822.772% |
| Atai Life Sciences N.V. | -36.31 Million USD | -350.178% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -105.571% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -101.031% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 40.667% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -431.763% |
| MediciNova, Inc. | -9.87 Million USD | -1554.499% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -29.794% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -10582.518% |
| GeoVax Labs, Inc. | -26.66 Million USD | -512.942% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 27.346% |
| Biomea Fusion, Inc. | -124.62 Million USD | -31.17% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 50.516% |
| Mereo BioPharma Group plc | -26.05 Million USD | -527.356% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 14.12% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 28.911% |
| Absci Corporation | -95.45 Million USD | -71.244% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -444.426% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -52.602% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 29.987% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -615.222% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 21.35% |
| Allakos Inc. | -189.91 Million USD | 13.928% |
| Imunon, Inc. | -19.87 Million USD | -722.325% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -50.669% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 250.903% |
| BioAtla, Inc. | -122.24 Million USD | -33.723% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1285.798% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -937.142% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 45.565% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -294.393% |
| XOMA Corporation | -39.36 Million USD | -315.284% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -64.693% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -38.941% |
| aTyr Pharma, Inc. | -52.17 Million USD | -213.281% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -95.03% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -9.98% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 30.312% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -1097.275% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -1932.553% |
| Akari Therapeutics, Plc | -16.8 Million USD | -872.884% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 86723.637% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 136.169% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -2458.673% |
| UroGen Pharma Ltd. | -63.83 Million USD | -156.089% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -140.689% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -2150.637% |
| Orgenesis Inc. | -60.71 Million USD | -169.218% |
| Entera Bio Ltd. | -8.8 Million USD | -1756.701% |
| GH Research PLC | -41.15 Million USD | -297.21% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -540.558% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -98.782% |
| Xencor, Inc. | -125.87 Million USD | -29.863% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -11358.734% |
| Replimune Group, Inc. | -230.19 Million USD | 28.99% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -710.929% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -1393.913% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -2458.673% |
| Portage Biotech Inc. | -18.19 Million USD | -798.203% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -10582.518% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -56.299% |
| OncoCyte Corporation | -23.12 Million USD | -606.932% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1346.538% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1326.781% |
| Purple Biotech Ltd. | -22.22 Million USD | -635.496% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -2450.14% |
| scPharmaceuticals Inc. | -46.06 Million USD | -254.886% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -817.838% |
| HilleVax, Inc. | -132.46 Million USD | -23.401% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -1437.327% |
| Tharimmune, Inc. | -9.3 Million USD | -1657.188% |
| Genprex, Inc. | -31.06 Million USD | -426.275% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 12.831% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -421.35% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -21295.812% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 108423.172% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1038038.89% |
| Savara Inc. | -59.13 Million USD | -176.434% |
| Curis, Inc. | -45.13 Million USD | -262.135% |
| Daré Bioscience, Inc. | -30.7 Million USD | -432.43% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -976.048% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -2181.424% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -511.446% |
| BeiGene, Ltd. | -1.12 Billion USD | 85.465% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -902.773% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 62.036% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -80.943% |
| Erasca, Inc. | -121.31 Million USD | -34.749% |
| bluebird bio, Inc. | -167.16 Million USD | 2.212% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -3533.538% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 152.682% |
| DBV Technologies S.A. | -85.98 Million USD | -90.114% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -3533.538% |
| Moderna, Inc. | -3.28 Billion USD | 95.021% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -283.637% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -2794.193% |
| Molecular Templates, Inc. | 1.43 Million USD | 11531.049% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -173.114% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 49.895% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -19.239% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -245.108% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -17.571% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 20.595% |
| MacroGenics, Inc. | 2.01 Million USD | 8204.313% |
| RenovoRx, Inc. | -11.39 Million USD | -1335.154% |
| Adicet Bio, Inc. | -136.53 Million USD | -19.723% |
| Prime Medicine, Inc. | -193.75 Million USD | 15.635% |
| Aditxt, Inc. | -25.45 Million USD | -542.094% |
| Adagene Inc. | -14.95 Million USD | -993.347% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2136.14% |
| Quantum-Si incorporated | -91.8 Million USD | -78.058% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 122.945% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 229.267% |
| SciSparc Ltd. | -5.28 Million USD | -2994.737% |
| Vericel Corporation | 2.86 Million USD | 5807.542% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -171591.454% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -653.588% |
| Generation Bio Co. | -133.3 Million USD | -22.629% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -96.873% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -90.024% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 28.127% |
| Invivyd, Inc. | -196.61 Million USD | 16.861% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 56.311% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -1662.453% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 701.989% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1489.344% |
| 2seventy bio, Inc. | -206.41 Million USD | 20.809% |
| ADMA Biologics, Inc. | 5.12 Million USD | 3292.656% |
| Clene Inc. | -43.24 Million USD | -278.03% |
| Capricor Therapeutics, Inc. | -23 Million USD | -610.436% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -237.199% |
| GeoVax Labs, Inc. | -26.66 Million USD | -512.942% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 45.433% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -345.05% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 793.437% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 3429.033% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -403.245% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -3.194% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 76.112% |
| Evaxion Biotech A/S | -21.4 Million USD | -663.743% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -146.125% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 24.902% |
| Trevena, Inc. | -35.28 Million USD | -363.228% |
| Surrozen, Inc. | -41.13 Million USD | -297.423% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -105.377% |
| Cingulate Inc. | -22.95 Million USD | -612.198% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -2090.913% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -338.441% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -1887.073% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -59.842% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -141.001% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -180.038% |
| Clearmind Medicine Inc. | -8.71 Million USD | -1776.597% |
| Kronos Bio, Inc. | -121.83 Million USD | -34.174% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -119.881% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -6595.464% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -62.123% |
| Statera Biopharma, Inc. | 38.93 Million USD | 519.839% |
| ImmunityBio, Inc. | -436.18 Million USD | 62.524% |
| Korro Bio, Inc. | -80.9 Million USD | -102.047% |
| Kineta, Inc. | -15.71 Million USD | -940.244% |
| BioVie Inc. | -31.95 Million USD | -411.621% |
| Codexis, Inc. | -49.28 Million USD | -231.684% |
| Celularity Inc. | -183.94 Million USD | 11.135% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 26.205% |
| Celcuity Inc. | -58.3 Million USD | -180.336% |
| Virax Biolabs Group Limited | -6.6 Million USD | -2373.301% |
| Cibus, Inc. | -314.58 Million USD | 48.038% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -384.582% |
| IN8bio, Inc. | -28.5 Million USD | -473.477% |
| Kodiak Sciences Inc. | -259.02 Million USD | 36.892% |
| Annexon, Inc. | -141.57 Million USD | -15.461% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -45.174% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -154.633% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -484.74% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 28.932% |
| Eyenovia, Inc. | -24.1 Million USD | -578.104% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 465.005% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -50351.852% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -121.484% |
| Arcellx, Inc. | -64.14 Million USD | -154.835% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -263.14% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -32.385% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -429.318% |
| Moolec Science SA | -52.07 Million USD | -213.898% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -216.754% |
| Geron Corporation | -174.78 Million USD | 6.475% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -304.444% |
| Royalty Pharma plc | 1.88 Billion USD | 108.661% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -36.684% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1653.105% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -688.129% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 1.575% |
| Humacyte, Inc. | -96.45 Million USD | -69.467% |
| Structure Therapeutics Inc. | -102.45 Million USD | -59.541% |
| 89bio, Inc. | -134.46 Million USD | -21.568% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -107.244% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 4134.156% |
| Genelux Corporation | -24.16 Million USD | -576.449% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -383.621% |
| Notable Labs, Ltd. | -14.4 Million USD | -1035.167% |
| Liquidia Corporation | -70.05 Million USD | -133.35% |
| Mustang Bio, Inc. | -48.06 Million USD | -240.104% |
| Immunovant, Inc. | -269.97 Million USD | 39.453% |
| Quantum-Si incorporated | -91.8 Million USD | -78.058% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -130.276% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -746.613% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -60.24% |
| Acasti Pharma Inc. | -11.3 Million USD | -1346.456% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -634.563% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -966.238% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 22.35% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -3727.889% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -929.37% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -468.057% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -341.437% |
| PepGen Inc. | -83.58 Million USD | -95.573% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -454.04% |
| United Therapeutics Corporation | 1.38 Billion USD | 111.787% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -613.91% |
| Solid Biosciences Inc. | -93.43 Million USD | -74.951% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -3325.671% |
| Immuneering Corporation | -58.06 Million USD | -181.539% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 5097200.094% |
| Silo Pharma, Inc. | -3.62 Million USD | -4407.842% |
| Belite Bio, Inc | -31.52 Million USD | -418.456% |
| XOMA Corporation | -39.36 Million USD | -315.284% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -142.359% |
| Bionomics Limited | -9.83 Million USD | -1561.727% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -94.635% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -372.357% |
| uniQure N.V. | -253.1 Million USD | 35.415% |
| Cassava Sciences, Inc. | -95.68 Million USD | -70.832% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2136.14% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -26.223% |
| Forte Biosciences, Inc. | -32.47 Million USD | -403.322% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -1930.489% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -479.269% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -50351.852% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1367.229% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -928.011% |
| Altimmune, Inc. | -87.93 Million USD | -85.892% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -77.526% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -372.357% |
| Compugen Ltd. | -12.51 Million USD | -1206.04% |
| Peak Bio, Inc. | -1356.23 USD | -12052722.899% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -236.36% |
| Benitec Biopharma Inc. | -22.49 Million USD | -626.83% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 32.537% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -472.694% |
| Zura Bio Limited | -60.56 Million USD | -169.907% |
| PolyPid Ltd. | -20.26 Million USD | -706.712% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -946.974% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -472.694% |
| Instil Bio, Inc. | -146.12 Million USD | -11.868% |
| argenx SE | -216.02 Million USD | 24.33% |
| Immunome, Inc. | -28.27 Million USD | -478.204% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -237.227% |
| Verona Pharma plc | -52.46 Million USD | -211.552% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -72.481% |
| Shattuck Labs, Inc. | -87.61 Million USD | -86.571% |
| CervoMed Inc. | -2.17 Million USD | -7426.403% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -33.719% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -1187.828% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -239.32% |
| Moolec Science SA | -52.07 Million USD | -213.898% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -853.7% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -25.364% |
| AnaptysBio, Inc. | -143.16 Million USD | -14.18% |
| Design Therapeutics, Inc. | -66.32 Million USD | -146.459% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -101.84% |
| NeurAxis, Inc. | -6.66 Million USD | -2352.759% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -333.017% |
| Lumos Pharma, Inc. | -36.57 Million USD | -346.989% |
| Achilles Therapeutics plc | -70.44 Million USD | -132.055% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -72.481% |
| 180 Life Sciences Corp. | -22.13 Million USD | -638.519% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 2904.204% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -6595.464% |
| Nutriband Inc. | -5.12 Million USD | -3091.549% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -48.945% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -194.891% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -223.371% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -150.416% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -202.096% |
| Palisade Bio, Inc. | -12.28 Million USD | -1231.032% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -260.243% |
| Beam Therapeutics Inc. | -156.47 Million USD | -4.468% |
| Neurogene Inc. | -52.28 Million USD | -212.634% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -19.763% |
| AEON Biopharma, Inc. | -48.36 Million USD | -238.008% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -75.734% |
| Sesen Bio, Inc. | -50.84 Million USD | -221.526% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -99.512% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -1223.593% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 61.757% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -55.388% |
| Athira Pharma, Inc. | -116.7 Million USD | -40.068% |
| Vaccinex, Inc. | -19.74 Million USD | -727.75% |
| HCW Biologics Inc. | -23.57 Million USD | -593.348% |
| XOMA Corporation | -39.36 Million USD | -315.284% |
| Nektar Therapeutics | -243.1 Million USD | 32.76% |
| Arvinas, Inc. | -394.8 Million USD | 58.596% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 86723.637% |
| Merus N.V. | -149.2 Million USD | -9.555% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -74.847% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -422.917% |
| Rezolute, Inc. | -68.42 Million USD | -138.902% |
| Clene Inc. | -43.24 Million USD | -278.03% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -959.927% |
| BeyondSpring Inc. | -21.54 Million USD | -658.886% |
| Synlogic, Inc. | -55.16 Million USD | -196.34% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -1252.843% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -1436.027% |
| Peak Bio, Inc. | -1356.23 USD | -12052722.899% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -403.508% |
| Krystal Biotech, Inc. | 17.9 Million USD | 1013.003% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -38.034% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 52.112% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -3448.603% |
| MannKind Corporation | 15.12 Million USD | 1180.468% |
| Ikena Oncology, Inc. | -74.39 Million USD | -119.719% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -1198.054% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 904.172% |
| Gossamer Bio, Inc. | -172.15 Million USD | 5.047% |
| CohBar, Inc. | -12.06 Million USD | -1254.776% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -540.809% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -444.426% |
| Legend Biotech Corporation | -477.87 Million USD | 65.793% |
| Mural Oncology plc | -192.72 Million USD | 15.181% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -43.322% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -912.458% |
| Disc Medicine, Inc. | -91.02 Million USD | -79.581% |
| Champions Oncology, Inc. | -5.05 Million USD | -3134.349% |
| REGENXBIO Inc. | -239.46 Million USD | 31.738% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1425.109% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -193.177% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -321.644% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -44.907% |
| Vaxart, Inc. | -74.72 Million USD | -118.76% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -364.277% |
| Cellectis S.A. | -98.09 Million USD | -66.638% |
| Longeveron Inc. | -20.06 Million USD | -714.875% |
| Repare Therapeutics Inc. | -114.27 Million USD | -43.047% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 62.781% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -118.5% |
| Revolution Medicines, Inc. | -430.58 Million USD | 62.036% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -2499.205% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -430.917% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -119.15% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 3433.959% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -1390.78% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 103.55% |
| Denali Therapeutics Inc. | -179.97 Million USD | 9.173% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -171591.454% |
| Veru Inc. | -89.97 Million USD | -81.676% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -508.17% |
| Cingulate Inc. | -22.95 Million USD | -612.198% |
| Passage Bio, Inc. | -98.34 Million USD | -66.222% |
| Context Therapeutics Inc. | -25.06 Million USD | -552.276% |
| Exicure, Inc. | -15.53 Million USD | -951.96% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 20.673% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -342.081% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -2641.49% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 2.968% |
| Nuvalent, Inc. | -149.49 Million USD | -9.346% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -1910.03% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -90.309% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -441.666% |
| OmniAb, Inc. | -49.73 Million USD | -228.696% |
| Anew Medical, Inc. | -1.3 Million USD | -12466.034% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -1222.096% |
| Lipocine Inc. | -16.32 Million USD | -901.454% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -145.184% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -119.997% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -328.666% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -318.988% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -636.889% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 70.01% |
| Ocugen, Inc. | -64.82 Million USD | -152.154% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -76.584% |
| Q32 Bio Inc. | -86.5 Million USD | -88.971% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -865.7% |
| Alumis Inc. Common Stock | -156.89 Million USD | -4.19% |
| Equillium, Inc. | -12.13 Million USD | -1246.713% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -179.559% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1968.288% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -766.678% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -250.09% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -53.711% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -813.891% |
| Dominari Holdings Inc. | -22.44 Million USD | -628.449% |
| Edesa Biotech, Inc. | -8.19 Million USD | -1895.863% |
| vTv Therapeutics Inc. | -25.41 Million USD | -543.255% |
| Bio-Techne Corporation | 326.66 Million USD | 150.041% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 57.527% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 175.542% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -24.679% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -336.708% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -8.182% |
| Nkarta, Inc. | -120.48 Million USD | -35.676% |
| BioCardia, Inc. | -11.56 Million USD | -1314.048% |
| Iterum Therapeutics plc | -34.58 Million USD | -372.713% |